Kidney Cancer Report 2025 (NKCA/NATCAN)

Reports | Published: 11 Sep 2025

The National Kidney Cancer Audit (NKCA), part of the National Cancer Audit Collaborating Centre (NATCAN), has published a report on care received by people diagnosed with kidney cancer from 2018-2022 in England, and from 2022-2023 in Wales. It also describes national trends in kidney cancer diagnoses and treatments in England from January 2019 to September 2024, and in Wales in 2022-2023.

82% of patients in England, and 99% in Wales, had a record of being discussed at a multidisciplinary team (MDT) meeting

The report found that 49% and 54% of people with metastatic Renal Cell Carcinoma (RCC) in England and Wales respectively received initial Systemic Anti-Cancer Therapy (SACT) within 12 months of diagnosis. Data revealed wide variation in provision of this treatment between different NHS Trusts and health boards. The authors identified that there is scope to improve access to SACT for patients with advanced disease, as it can improve quality of life, extend survival, and alleviate cancer-related symptoms.

The percentage of people receiving SACT within 31 days of a decision to treat has declined from 76% in 2019 to 63% in 2022, showing a concerning downward trend. In England, NHS trust-level interquartile range was 57-79%, and notably, no Cancer Alliance achieved the NHS England standard of 96% compliance. Trusts and health boards should identify people with high-risk RCC, and ensure they receive treatment without delay.

This report contains five recommendations that were developed in collaboration with the NKCA Clinical Reference Group, and are based on key findings. Recommendations focus on diagnostics and treatment pathways.

Read the full report: You can view the report by clicking the button below.

Stay up-to-date: For notifications of future reports from HQIP, sign up to our mailing list.

More cancer reports: This month, HQIP has published 7 reports on cancer care – to see all others, go to our reports page.

More information: For further information and related reports, go to the programme page on this website.

Don’t miss out. Sign up to be notified when this resource is updated and to receive updates about other related quality improvement resources, events and news from HQIP. Or you can  .


By continuing you agree to receive emails with updates and other information from HQIP and you are confirming you are over the age of 13.

Please read our privacy policy to understand how HQIP uses the information you provide, your use of HQIP’s website and your interaction with the marketing emails to improve the relevance of the communications we send you. You can unsubscribe at any time.

I have read and agree with the contents of the privacy policy.

Kidney Cancer Report 2025 (NKCA/NATCAN)